RSLDX
Price
$73.48
Change
-$0.78 (-1.05%)
Updated
Jul 11 closing price
Net Assets
78.5B
VVPSX
Price
$12.40
Change
-$0.17 (-1.35%)
Updated
Jul 11 closing price
Net Assets
130.78M
Interact to see
Advertisement

RSLDX vs VVPSX

Header iconRSLDX vs VVPSX Comparison
Open Charts RSLDX vs VVPSXBanner chart's image
American Funds SMALLCAP World R5E
Price$73.48
Change-$0.78 (-1.05%)
VolumeN/A
Net Assets78.5B
Vulcan Value Partners Small Cap
Price$12.40
Change-$0.17 (-1.35%)
VolumeN/A
Net Assets130.78M
RSLDX vs VVPSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSLDX vs. VVPSX commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLDX is a Buy and VVPSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 78.5B vs. VVPSX (131M). VVPSX pays higher dividends than RSLDX: VVPSX (1.15) vs RSLDX (0.81). RSLDX was incepted earlier than VVPSX: RSLDX (10 years) vs VVPSX (16 years). VVPSX (1.27) is less costly to investors than RSLDX (0.80). VVPSX (33.00) and RSLDX (32.00) have comparable annual turnover. RSLDX has a lower initial minimum investment than VVPSX: RSLDX (250) vs VVPSX (5000). RSLDX annual gain was more profitable for investors over the last year : 7.32 vs. VVPSX (-0.03). RSLDX return over 5 years is better than : 19.88 vs. VVPSX (1.99).
RSLDXVVPSXRSLDX / VVPSX
Total Expense Ratio0.801.2564%
Annual Report Gross Expense Ratio0.801.2763%
Fund Existence10 years16 years-
Gain YTD7.9514.907162%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets78.5B131M59,924%
Annual Yield % from dividends0.811.1570%
Returns for 1 year7.32-0.03-26,597%
Returns for 3 years35.501.003,546%
Returns for 5 years19.881.99999%
Returns for 10 yearsN/A-30.42-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLRX1.410.01
+0.71%
Pliant Therapeutics
FFIV291.89-8.00
-2.67%
F5, Inc.
DNLI14.52-0.83
-5.41%
Denali Therapeutics
UUU3.33-0.23
-6.33%
Universal Security Instruments
PLSE16.03-1.09
-6.37%
Pulse Biosciences